If you are wondering whether Omnicell is attractively priced today, the key question is whether the current share price still lines up with the company’s underlying value. After a long stretch of ...

6,106 shares were sold for a transaction value of $243,629 on Dec. 3, 2025. The sale represented 5.85% of direct holdings, reducing direct ownership to 98,282 shares (0.2122% of shares outstanding).

Wells Fargo raised the firm’s price target on Omnicell (OMCL) to $52 from $43 and keeps an Overweight rating on the shares. The firm added ...

Omnicell, Inc. OMCL has witnessed strong momentum in the past year. Shares of the company have risen 41.6% against a 11.3% decline of the industry during the same time frame. The S&P 500 composite has ...

Omnicell is growing its portfolio of medication management solutions and adherence tools. The Mountain View, Calif.-based company has entered into a definitive agreement with pharmacy software ...

Mercyhealth has chosen to implement Omnicell‘s XR2 Automated Central Pharmacy System in an effort to increase its pharmacy’s efficiency and improve patient safety. The technology will be adopted at ...

Omnicell, Inc. (Nasdaq: OMCL),a leader in transforming the pharmacy and nursing care delivery model, will host an Innovation Update and Investor Q&A Session during the upcoming ASHP Midyear Clinical ...

Omnicell reported that some of its information technology systems were affected by ransomware. On May 4, Omnicell, a provider of medication management and adherence tools for health systems and ...

Omnicell (NASDAQ:OMCL) priced $150 million principal amount of 1.00% convertible senior notes due 2029, with an option to buy an additional $22.5 million for underwriters. Omnicell plans to raise $144 ...

The company continues to benefit from demand for its next-generation healthcare tech offerings. Revenue for Omnicell in its third quarter amounted to $311 million, notching the company a 10% gain in ...